@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix go: . @prefix Protein: . @prefix rgd: . @prefix geneProductOf: . @prefix hasAgent: . @prefix obo: . @prefix occursIn: . @prefix species: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 hasAgent: sub:_2; a go:0003824 . sub:_2 geneProductOf: rgd:3242; a Protein: . sub:_3 hasAgent: sub:_4; a go:0005525 . sub:_4 geneProductOf: rgd:619921; a Protein: . sub:_5 occursIn: obo:CL_0000187, obo:UBERON_0004535, species:10116; rdf:object sub:_3; rdf:predicate belv:increases; rdf:subject sub:_1; a rdf:Statement . sub:assertion rdfs:label "cat(p(RGD:P2ry1)) -> gtp(p(RGD:Rhoa))" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_7; pav:version "20131211" . sub:_6 prov:value "Agonists can activate RhoA through numerous G protein-coupled receptors: alpha-adrenergic, muscarinic, prostanoid (75, 146, 166, 325), purinergic (332), endothelin (412), thrombin (90, 241, 398), vasopressin (220, 376), oxytocin, epidermal growth factor, purinergic, ephrin, semaphorin; angiotensin and EDG lysophospholipid (365, 386) receptors (e.g., Refs. 9, 16, 68, 75, 87, 90, 114, 130, 146, 150, 153, 155, 166, 241, 263, 293, 332, 379, 406, 411, 437 and reviewed in Refs. 321, 338, 357, 358)."; prov:wasQuotedFrom pubmed:14506307 . sub:_7 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:14506307; prov:wasDerivedFrom beldoc:, sub:_6 . } sub:pubinfo { this: dct:created "2014-07-03T14:32:09.345+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }